CoImmune Patents – Insights & Stats (Updated 2023)

CoImmune has a total of 142 patents globally, out of which 92 have been granted. Of these 142 patents, more than 76% patents are active. The United States of America is where CoImmune has filed the maximum number of patents, followed by Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of CoImmune.

CoImmune was founded in 2019. CoImmune is a clinical-stage immuno-oncology company that is privately held and aims to revolutionize cancer therapy using cellular immunotherapies. The company’s innovative CAR therapy, the allogeneic CAR-CIK technology platform for liquid and solid malignancies, promises improved efficacy with significantly less toxicity.

Do read about some of the most popular patents of CoImmune which have been covered by us in this article and also you can find CoImmune patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CoImmune patent portfolio.

How many patents does CoImmune have?

CoImmune has a total of 142 patents globally. These patents belong to 31 unique patent families. Out of 142 patents, 109 patents are active.

How Many Patents did CoImmune File Every Year?

CoImmune Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCoImmune Applications FiledCoImmune Patents Granted
20231
202233
202194
202054
201934
201856
201737
201668
2015114
2014312
2013614
2012711
201136

How many CoImmune patents are Alive/Dead?

Worldwide Patents

CoImmune Patent Portfolio

How Many Patents did CoImmune File in Different Countries?

CoImmune Worldwide Patent Filing

Countries in which CoImmune Filed Patents

CountryPatent
United States Of America56
Australia20
Korea (South)13
Canada13
Europe9
China8
Israel6
Hong Kong (S.A.R.)5
Germany3
Spain2
Austria1
Japan1
South Africa1
Italy1
Norway1

Where are Research Centers of CoImmune Patents Located?

R&D Centres of CoImmune

10 Best CoImmune Patents

US8030080B2 is the most popular patent in the CoImmune portfolio. It has received 64 citations so far from companies like Rheonix, Theranos, Abbott.

Below is the list of 10 most cited patents of CoImmune:

Publication NumberCitation Count
US8030080B264
US7169898B230
US8672879B226
US8211701B218
US7198948B214
US20120269832A112
US8431404B211
US7785583B211
US8236562B27
US20130280805A16

What are CoImmune key innovation segments?

What Technologies are Covered by CoImmune?

The chart below distributes patents filed by CoImmune in different countries on the basis of the technology protected in patents. It also represents the markets where CoImmune thinks it’s important to protect particular technology inventions.

R&D Focus: How has CoImmune search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by CoImmune?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.